Search details
1.
Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case-control validation study.
Histopathology
; 85(1): 62-74, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38477417
2.
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre.
Int J Mol Sci
; 24(4)2023 Feb 17.
Article
in English
| MEDLINE | ID: mdl-36835466
3.
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer.
Int J Mol Sci
; 24(10)2023 May 18.
Article
in English
| MEDLINE | ID: mdl-37240284
4.
An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach.
Int J Mol Sci
; 21(19)2020 Sep 29.
Article
in English
| MEDLINE | ID: mdl-33003368
5.
Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance.
Virchows Arch
; 484(2): 289-319, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38108848
6.
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis.
Pathol Res Pract
; 254: 155142, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38277752
7.
Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel.
Diagnostics (Basel)
; 14(8)2024 Apr 11.
Article
in English
| MEDLINE | ID: mdl-38667446
8.
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
Thyroid
; 34(2): 167-176, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37842841
9.
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice.
Front Med (Lausanne)
; 10: 1146499, 2023.
Article
in English
| MEDLINE | ID: mdl-37064027
10.
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma.
J Pers Med
; 13(5)2023 Apr 25.
Article
in English
| MEDLINE | ID: mdl-37240893
11.
Inducing respiratory complex I impairment elicits an increase in PGC1α in ovarian cancer.
Sci Rep
; 12(1): 8020, 2022 05 16.
Article
in English
| MEDLINE | ID: mdl-35577908
12.
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer.
Noncoding RNA
; 8(5)2022 Sep 25.
Article
in English
| MEDLINE | ID: mdl-36287116
13.
Gut Microbiota Dynamics during Chemotherapy in Epithelial Ovarian Cancer Patients Are Related to Therapeutic Outcome.
Cancers (Basel)
; 13(16)2021 Aug 08.
Article
in English
| MEDLINE | ID: mdl-34439153
14.
ARID1A and CTNNB1/ß-Catenin Molecular Status Affects the Clinicopathologic Features and Prognosis of Endometrial Carcinoma: Implications for an Improved Surrogate Molecular Classification.
Cancers (Basel)
; 13(5)2021 Feb 25.
Article
in English
| MEDLINE | ID: mdl-33668727
15.
Plasma-activated Ringer's Lactate Solution Displays a Selective Cytotoxic Effect on Ovarian Cancer Cells.
Cancers (Basel)
; 12(2)2020 Feb 18.
Article
in English
| MEDLINE | ID: mdl-32085609
16.
Correction to: Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance.
Virchows Arch
; 484(2): 321, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38277053
17.
Potential Prognostic Role of 18F-FDG PET/CT in Invasive Epithelial Ovarian Cancer Relapse. A Preliminary Study.
Cancers (Basel)
; 11(5)2019 May 23.
Article
in English
| MEDLINE | ID: mdl-31126127
Results
1 -
17
de 17
1
Next >
>>